- Home
- CLRB vs PRPH Comparison
CLRB vs PRPH Comparison
Compare CLRB & PRPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CLRB
- PRPH
- Stock Information
- Founded
- CLRB 2002
- PRPH 1989
- Country
- CLRB United States
- PRPH United States
- Employees
- CLRB N/A
- PRPH N/A
- Industry
- CLRB Biotechnology: Pharmaceutical Preparations
- PRPH Biotechnology: Pharmaceutical Preparations
- Sector
- CLRB Health Care
- PRPH Health Care
- Exchange
- CLRB Nasdaq
- PRPH Nasdaq
- Market Cap
- CLRB 17.6M
- PRPH 15.2M
- IPO Year
- CLRB N/A
- PRPH 1997
- Fundamental
- Price
- CLRB $4.92
- PRPH $0.36
- Analyst Decision
- CLRB Hold
- PRPH
- Analyst Count
- CLRB 2
- PRPH 0
- Target Price
- CLRB N/A
- PRPH N/A
- AVG Volume (30 Days)
- CLRB 173.9K
- PRPH 813.9K
- Earning Date
- CLRB 08-12-2025
- PRPH 08-13-2025
- Dividend Yield
- CLRB N/A
- PRPH N/A
- EPS Growth
- CLRB N/A
- PRPH N/A
- EPS
- CLRB N/A
- PRPH N/A
- Revenue
- CLRB N/A
- PRPH $5,845,000.00
- Revenue This Year
- CLRB N/A
- PRPH $221.82
- Revenue Next Year
- CLRB N/A
- PRPH N/A
- P/E Ratio
- CLRB N/A
- PRPH N/A
- Revenue Growth
- CLRB N/A
- PRPH N/A
- 52 Week Low
- CLRB $4.36
- PRPH $0.22
- 52 Week High
- CLRB $94.50
- PRPH $3.37
- Technical
- Relative Strength Index (RSI)
- CLRB 36.75
- PRPH 46.36
- Support Level
- CLRB $4.74
- PRPH $0.35
- Resistance Level
- CLRB $5.33
- PRPH $0.46
- Average True Range (ATR)
- CLRB 0.40
- PRPH 0.03
- MACD
- CLRB -0.00
- PRPH -0.01
- Stochastic Oscillator
- CLRB 18.43
- PRPH 19.36
About CLRB Cellectar Biosciences Inc.
Cellectar Biosciences Inc is a clinical-stage biopharmaceutical company. It is focused on the discovery, development, and commercialization of drugs for the treatment of cancer. The company's core objective is to leverage a proprietary phospholipid drug conjugate (PDC) delivery platform to develop PDCs that are designed to specifically target cancer cells and deliver improved efficacy and safety as a result of fewer off-target effects. It has one operating and reportable segment focused on utilizing its PDC platform to develop drugs for the treatment of cancer.
About PRPH ProPhase Labs Inc. (DE)
ProPhase Labs Inc is a diversified company offering various services, including diagnostic testing, genomics testing, and contract manufacturing. Its operating segments include Diagnostic services and Consumer products. The Diagnostic segment provides COVID-19 diagnostic information services to a broad range of customers in the United States, including health plans, third-party payers, and government organizations. The Consumer Products segment is engaged in the research, development, manufacture, distribution, marketing, and sale of OTC consumer healthcare products and dietary supplements in the United States. It also provides personal genomics products and services.